# Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery

> **NCT00151853** · PHASE4 · COMPLETED · sponsor: **Prothya Biosolutions** · enrollment: 40 (—)

## Conditions studied

- CPB
- Oral Anticoagulant Therapy

## Interventions

- **DRUG:** PPSB-SD

## Key facts

- **NCT ID:** NCT00151853
- **Lead sponsor:** Prothya Biosolutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151853, "Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00151853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*